FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 01/08/2018 |
3. Issuer Name and Ticker or Trading Symbol
CARLISLE COMPANIES INC [ CSL ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 26,456(1) | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Common Stock Options | (2) | 02/05/2023 | Common Stock | 10,290 | $64.8 | D | |
Common Stock Options | (3) | 02/04/2024 | Common Stock | 9,645 | $73.08 | D | |
Common Stock Options | (4) | 02/03/2025 | Common Stock | 8,635 | $92.46 | D | |
Common Stock Options | (5) | 02/02/2026 | Common Stock | 9,460 | $83.31 | D | |
Common Stock Options | (6) | 02/07/2027 | Common Stock | 8,305 | $107.73 | D |
Explanation of Responses: |
1. Consists of (i) 19,438 shares held in nominee form, (ii) 1,800 performance shares previously granted, vested, and earned that have been deferred into the issuer's non-qualified deferred compensation plan, (iii) 4,285 previously awarded restricted shares, and (iv) 933 shares held in the issuer's qualified defined contribution plan. |
2. 3,430 options exercisable on each of February 6, 2014, February 6, 2015 and February 6, 2016, cumulatively. |
3. 3,215 options exercisable on each of February 5, 2015, February 5, 2016 and February 5, 2017, cumulatively. |
4. 2,878 options exercisable on each of February 4, 2016 and February 4, 2017 and 2,879 options exercisable on February 4, 2018, cumulatively. |
5. 3,153 options exercisable on each of February 3, 2017 and February 3, 2018 and 3,154 options exercisable on February 3, 2019, cumulatively. |
6. 2,768 options exercisable on each of February 8, 2018 and February 8, 2019 and 2,769 options exercisable on February 8, 2020, cumulatively. |
Remarks: |
/s/ Trent A. Freiberg by Michael L. Roberson attorney-in-fact | 01/16/2018 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |